Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $274.88 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $129.36 | 2 | $0 (2024) |
| ABBVIE INC. | $49.36 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $45.43 | 3 | $0 (2018) |
| Astute Medical, Inc. | $20.94 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $17.11 | 1 | $0 (2024) |
| Amgen Inc. | $12.68 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85.69 | 4 | ABBVIE INC. ($49.36) |
| 2021 | $110.14 | 1 | Janssen Pharmaceuticals, Inc ($110.14) |
| 2019 | $12.68 | 1 | Amgen Inc. ($12.68) |
| 2018 | $66.37 | 4 | AstraZeneca Pharmaceuticals LP ($45.43) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.11 | General |
| Category: Cardiovascular | ||||||
| 04/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/29/2024 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $33.86 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $110.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/04/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Bone Health | ||||||
| 08/07/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/11/2018 | Astute Medical, Inc. | Nephrocheck (Device) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Nephrology | ||||||
| 02/20/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.04 | General |
| 01/09/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.90 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 659 | 1,086 | $350,594 | $89,178 |
| 2022 | 5 | 756 | 1,363 | $425,611 | $104,228 |
| 2021 | 5 | 683 | 1,365 | $382,758 | $103,947 |
| 2020 | 5 | 720 | 1,336 | $390,885 | $112,414 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 188 | 354 | $126,104 | $33,649 | 26.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 235 | 491 | $125,026 | $31,703 | 25.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 210 | 215 | $81,289 | $20,122 | 24.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 26 | $18,175 | $3,705 | 20.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 271 | 634 | $216,091 | $53,310 | 24.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 213 | 451 | $108,351 | $25,896 | 23.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 209 | 215 | $76,326 | $18,655 | 24.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $16,140 | $4,357 | 27.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 35 | 35 | $8,703 | $2,010 | 23.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 257 | 688 | $157,304 | $41,903 | 26.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 164 | 406 | $131,635 | $36,785 | 27.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 207 | 215 | $72,449 | $19,403 | 26.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 21 | 21 | $13,310 | $3,701 | 27.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 34 | 35 | $8,060 | $2,156 | 26.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 226 | 579 | $181,857 | $53,289 | 29.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 205 | 453 | $97,277 | $27,421 | 28.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 226 | 240 | $77,328 | $21,777 | 28.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 52 | 53 | $32,036 | $9,246 | 28.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 11 | 11 | $2,387 | $681.32 | 28.5% |
About Dr. Denise Sakyi, M.D
Dr. Denise Sakyi, M.D is a Internal Medicine healthcare provider based in Evergreen Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2016. The National Provider Identifier (NPI) number assigned to this provider is 1679925531.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Denise Sakyi, M.D has received a total of $274.88 in payments from pharmaceutical and medical device companies, with $85.69 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($274.88).
As a Medicare-enrolled provider, Sakyi has provided services to 2,818 Medicare beneficiaries, totaling 5,150 services with total Medicare billing of $409,768. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Evergreen Park, IL
- Active Since 07/04/2016
- Last Updated 02/10/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679925531
Products in Payments
- XARELTO (Drug) $129.36
- TEFLARO (Drug) $33.86
- Nephrocheck (Device) $20.94
- CAMZYOS (Drug) $17.11
- AVYCAZ (Drug) $15.50
- BRILINTA (Drug) $14.49
- Prolia (Biological) $12.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Evergreen Park
Dr. Abdallah Altarshan, Md, MD
Internal Medicine — Payments: $232,323
Dr. Mohammad Tarek Kabbany, M.d, M.D
Internal Medicine — Payments: $19,253
Dr. Syed Moeed, M.d, M.D
Internal Medicine — Payments: $7,514
Mohammad Razzaque, M.d, M.D
Internal Medicine — Payments: $6,592
Satwant Kingra, Md, MD
Internal Medicine — Payments: $5,760
Dr. Hamdi Khilfeh, M.d, M.D
Internal Medicine — Payments: $5,168